Glenmark Pharmaceuticals has informed that it has enclosed press release titled 'Glenmark Pharmaceuticals receives ANDA approval for Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg'.
The above information is a part of company’s filings submitted to BSE.